Dr. Ernie Bowling: Good news is out there during COVID-19

Article

Ernie Bowling, OD, FAAO, says all he sees and hears is bad news. He offers hope and good news to offset the not-so-good news amid COVID-19. Read his companion article, "Hope in the time of COVID-19".

Related: Dry eye in the digital age

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Related Content
This news follows the announcement from Opthea that it plans to discontinue its COAST and ShORe trials. Image credit: AdobeStock/dang/AI

Opthea to lay off 65% of company following announcement of clinical trial discontinuation

Martin David Harp, Editor, Ophthalmology Times
April 11th 2025
Article
New Opportunities in Topical Glaucoma Management

New Opportunities in Topical Glaucoma Management

Mitch Ibach, OD, FAAO;Jessica Steen, OD, FAAO
January 31st 2025
Podcast
CRU 2025 graphic

CRU 2025: Rethinking first-line glaucoma therapy

Jordana Joy, Associate Editor
April 11th 2025
Article
You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

Miriam Korik, OD;Tiffany Tsoi, OD;Emily Kaiser Maharjan, Assistant Managing Editor
December 4th 2024
Podcast
Klarity-C users can switch to Vevye following Harrow's expansion of Vevye Access for all - ©Andrey Nikitin

Harrow expands Vevye Access for All program to encourage switch from Klarity-C

Emily Kaiser Maharjan, Assistant Managing Editor
April 10th 2025
Article
CRU 2025 graphic

CRU 2025: The ABCs of DED and OSD

Jordana Joy, Associate Editor
April 10th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.